
|Videos|January 10, 2023
Developing an active surveillance protocol for patients receiving a diagnosis of prostate cancer after HoLEP
Author(s)Urology Times staff
Ashley E. Ross, MD, PhD, provides an overview of his institution’s new protocol for this subset of patients.
Advertisement
In this video, Ashley E. Ross, MD, PhD, discusses an active surveillance protocol for patients undergoing holmium laser enucleation of the prostate for benign prostatic hyperplasia who subsequently receive a diagnosis of prostate cancer. Ross is an associate professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves first-line Zenflow system for the treatment of BPH
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5


















